| mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.8 |
| mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.8 |
| mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
0.0064 |
0.8 |
| mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0072 |
0.8 |
| mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.8 |
| mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.0062 |
0.9 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0059 |
0.9 |
| mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
-0.0057 |
0.9 |
| mRNA |
BRD-A02303741 |
CTRPv2 |
pan-cancer |
AAC |
0.0068 |
0.9 |
| mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
-0.0077 |
0.9 |